Skip to main content
OpenTrials
Completed

NCT Number: NCT04949230

A Retrospective Study of COVID-19 Treatments

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  • Male or female of 18 years of age or older
  • Diagnosis of COVID-19 infection by RT- PCR
  • Recovery from COVID-19

Exclusion criteria

Treatment and study plan

No intervention used

Other

There is no intervention in this study

Primary outcomes

  1. Survey Response

    Time frame: One hour

    Answers given by subjects on their recovery from COVID-19

Sponsors and collaborators

Lead sponsor

ProgenaBiome

Other

Registry information

Official study title

A Retrospective Study to Analyze Efficacy of COVID-19 Treatments

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Jul 2, 2021
Registry last updated
Feb 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.